Android
Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account

Syngene International Ltd585.95 1.50 (0.26%)

  • BSE: 539268
  • |
  • NSE: SYNGENE
  • |
  • ISIN NO: INE398R01022
  • |
  • INDUSTRY: Pharmaceuticals
Profile

SYNGENE

SYNGENE

It was incorporated as Syngene International Private Limited as on November 18, 1993, at Bengaluru, Karnataka as a private limited company under the Companies Act, 1956. According to a special resolution of the shareholders dated March 26, 2007, the Company was being converted into a public limited company, and the company name was changed to Syngene International Limited. Also, a fresh certificate of incorporation consequent upon conversion to the public limit ... ed company was issued as on April 19, 2007. It was also promoted by Kiran Mazumdar Shaw, who is a promoter of Biocon. On March 30, 2002, 99.9% of the Equity Shares of the Company were being transferred to Biocon, and as a result, it became the subsidiary of Biocon. It has also since been the Promoter of the Company. Also, the details of changes in the registered office of the Company are given below: From 20th KM, Hosur Road, Electronics City P.O, Bengaluru 560 100, Karnataka, India to Biocon Special Economic Zone, Biocon Park, Plot No. 2 and 3, Bommasandra Industrial Area IV Phase, Jigani Link Road, Bommasandra, Bengaluru 560 099, Karnataka, India.

Some of the Milestones:

  • 1994: It initiated operations as a CRO with services in chemistry and biology.
  • 1998: It granted 100% Export Oriented Unit (EOU) status by the Government of India.
  • 1999: Its first operational expansion in R&D by way of expansion of lab space to over 23,000 sq. Ft.
  • 2000: Also, CIL was incorporated as a 100% subsidiary of Biocon to provide clinical research services to domestic and multinational companies.
  • 2001: It forayed into chemical development with a dedicated manufacturing facility.
  • 2003: It moved to Biocon Park, a 90-acre biopharmaceutical SEZ with the operations spread over 65,000 sq. Ft.
  • 2007:
  • Both Bristol-Myers Squibb and the Company signed the first long term contract to set up the first dedicated R&D center.
  • The expansion of research facilities located at Biocon SEZ to 148,000 sq. Ft.
  • It crossed an annual turnover of over `1,000 million in Financial Year 2007.
  • 2009:
  • Both Dupont Crop Protection and the Company extended a partnership for R&D services.
  • The expansion of manufacturing services with a new plant which is cGMP compliant.
  • It initiated operations in safety assessment and large molecules development services.
  • 2010:
  • Also, the acceptance of the clinical and bio-analytical facilities of CIL by the Department of Health & Human Services, FDA.
  • It initiated operations in formulation development.
  • 2011: Both Endo Pharmaceuticals and the Company collaborated to develop novel biological therapeutic molecules against cancer.
  • 2012:
  • Both Abbott and the Company collaborated to establish Abbott's nutrition research and development center in India and the second R&D center.
  • It received the certification of the clinical facilities by ANVISA.
  • It acquired a 100% stake in Clinigene International Limited from Biocon.
  • 2013:
  • It crossed an annual turnover of over INR 5,000 million in Financial Year 2013.
  • Also, the Baxter International Inc. collaborated with the Company to establish the ‘Baxter Global Research Center,’ the third dedicated R&D center.
  • The acceptance of the control testing laboratory by the Department of Health & Human Services, FDA.
  • 2014:
  • Both Bristol-Myers Squibb and the Company extend collaboration for its dedicated R&D center till 2020.
  • The acceptance of the API manufacturing facility by the Department of Health & Human Services, FDA.
  • It also established a 75,000 sq.ft center to provide stability and analytical services.
  • 2015: Also, the CIL was amalgamated with the Company.

Some of the Achievements:

  • 2009:
  • It received Bangalore Bio, Bio Excellence Award, in Biotech Services Sector.
  • It won the Best BioServices Company of the year from Biospectrum.
  • 2012:
  • It received ISO 9001:2008 for contract research in drug discovery and contract manufacturing of biopharmaceuticals.
  • It received AAALAC accreditation for conforming to the “Guide for the Care and Use of Laboratory Animals and the Committee for Control & Supervision of the Experiments on Animals guidelines.”
  • 2013:
  • It received Bioservices - ABLE Tenth Anniversary Award for the outstanding contribution to Bioservices.
  • It received Diamond Sponsor recognition by the Association of Scientists of Indian Origin of the Society of Toxicology.
  • 2014:
  • It received ISO 14001:2004 for contract research in drug discovery and contract manufacturing of biopharmaceuticals.
  • It received BS OHSAS 18001:2007 for contract research in drug discovery and contract manufacturing of biopharmaceuticals.
  • It received a Silver EDGE Award.
  • It received the EHS best practices award by CII.
  • It received SAP Ace Award for special recognition for complex SAP implementation.
  • 2015:
  • Also, the accreditation by the College of American Pathologists concerning their laboratory accreditation program.
  • It received Bangalore India Bio - Bio Excellence Award for an outstanding contribution to the Biotech services sector.
  • It received ISO 15189:2007 in the field of medical testing.
  • 2017:
  • Both Herbalife Nutrition Partners with Syngene to Establish Nutrition Research and Development Lab in India.
  • The "Syngene International Announces Broadening of Research Collaboration with Amgen Inc." and expands the Dedicated R&D Center.
  • Both "Bristol-Myers Squibb and Syngene International Expand for an Ongoing Research Collaboration."

Read More
Key Data
  • Market cap 14284.00 CR.
  • Book value 54.35
  • Stock P/E 66
  • Dividend Yield 0.14%
  • ROCE 16.72%
  • ROE 17.75%
  • Sales Growth (3Y) 18.15%
  • Face Value (3Y) 10.00
Trend Analysis
  • Short Term Trend :
    Not clear
  • Medium Term Trend :
    Not Clear
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
TIME LOWEST HIGHEST
10 AM - -
11 AM - -
12 PM - -
1 PM - -
2 PM - -
Japanese Candlestick Patterns
Candle Pattern 1 :None
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Lower High Lower Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 509.28 536.63 563.98 574.22 591.33 601.57 618.68 646.03 673.38
woodie's 537.63 564.98 573.04 592.32 600.39 619.68 627.74 647.02 674.38
fibonacci - 563.98 574.43 580.89 591.33 601.78 608.24 618.68 -
camarilla 569.41 576.93 579.44 581.94 -- 586.96 589.46 591.97 599.49
Past Performance & Moving Averages
Day’s LOW HIGH RANGE SMA PERFORMANCE Nifty
10 DAY 574.45
624.00
602.81 -2.70 % 0.10 %
20 DAY 574.45
644.55
610.63 -5.90 % 2.30 %
50 DAY 538.00
644.55
596.67 2.18 % 8.53 %
100 DAY 443.00
644.55
568.20 5.96 % 21.59 %
200 DAY 270.10
644.55
481.95 40.49 % 33.90 %
YTD 574.45
639.90
609.63 -6.94 % 2.72 %
52 Week 212.55
644.55
402.29 91.62 % 18.71 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Unfilled Gap Up On 2020-09-14
520.05 ~ 492.00 SUPPORT
Unfilled Gap Up On 2020-09-10
463.20 ~ 459.90 SUPPORT
Unfilled Gap Up On 2020-07-24
441.50 ~ 441.00 SUPPORT
Unfilled Gap Up On 2020-04-07
261.00 ~ 259.90 SUPPORT
Unfilled Gap Down On 2019-06-11
345.00 ~ 651.50 RESISTANCE
Industry Growth Rate

In Last 1 Year the industry has grown by -22.99 %

In Last 5 Year the industry has grown by 0.00 %

Peer comparison

Sales

COMPANY NAME20152016201720182019
SYNGENE 1423.001826.00
SUNPHARMA27392.0028487.0031578.0026489.0029066.00
LUPIN12770.0014256.0017367.0015797.0016718.00
CIPLA11345.0013790.0014394.0015156.0016362.00
AUROPHARMA12103.0013772.0014910.0016463.0019564.00
Total 15065.60 16707.20 15902.50 17576.25 19562.25 15065.60

Financial

LAST FISCAL CURRENT GROWTH 10 YEAR CAGR
S.NO. COMPANY NAME MARKET CAP CMP BOOK VALUE EPS STOCK P/E ROE ICR REVENUE NET PROFIT NPM REVENUE NET PROFIT REVENUE NET PROFIT
1 SUN PHARMACEUTICAL INDUSTRIES LTD. 140749.98 586.55 98.33
2 MARKSANS PHARMA LTD. 92969.02 22.65 11.85
3 MOREPEN LABORATORIES LTD. 71575.87 15.90 6.43
4 NEULAND LABORATORIES LTD. 50071.35 390.75 542.16
5 GUFIC BIOSCIENCES LTD. 41419.69 53.30 10.85
6 DIVI'S LABORATORIES LTD. 94752.62 3570.80 266.77
7 DR.REDDY'S LABORATORIES LTD. 84481.12 5085.00 852.69
8 RPG LIFE SCIENCES LTD. 41788.21 252.45 105.02
9 SMS PHARMACEUTICALS LTD. 34236.68 40.25 42.07
10 CIPLA LTD. 67467.40 837.10 209.71
11 TORRENT PHARMACEUTICALS LTD. 44630.96 2636.20 323.66
12 PIRAMAL ENTERPRISES LTD. 33083.93 1466.80 823.58
13 LUPIN LTD. 49020.91 1081.85 384.76
14 NECTAR LIFESCIENCES LTD. 29495.44 13.16 49.89
15 AUROBINDO PHARMA LTD. 58447.83 998.00 206.07
16 Alkem Laboratories Ltd 37265.41 3104.15 501.34
17 ABBOTT INDIA LTD. 31017.36 14547.00 1004.00
18 CADILA HEALTHCARE LTD. 47812.38 466.85 90.85
19 GLAXOSMITHKLINE PHARMACEUTICALS LTD. 25217.23 1488.90 138.61
20 KILITCH DRUGS (INDIA) LTD. 13893.00 89.90 98.74
Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Profitability

What is Profit & EPS Trend ?

EPS Trends was initially built in late 2015 when I was just getting into frontend development. Coming from a background in Rails, I was frustrated with how many decisions you had to make early on as a javascript developer.

Net Profit
EPS

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA Margin
EBIT Margin
NPM
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • 5.54
    Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 7.22
    Safe (2.6 & above)
Valuation

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Ratio Analysis

The Bank was incorporated in the year 2004 by Rana Kapoor and Late Ashok Kapur, which is a new age private sector bank. And since the inception of the bank has fructified into a “Full-Service Commercial Bank,” it has steadily built Corporate and Institutional Banking, Financial Markets, Investment Banking, Corporate Finance, Branch Banking, Business and Transaction Banking, and Wealth Management business lines across the whole country.

It is well-equipped to offer a spectrum of products and services to all the corporate and retail customers.

Read More
Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
SYNGENE 2017-11-23 GAOLING FUND LP P 1500000.00 515.00
SYNGENE 2017-11-23 STEADVIEW CAPITAL MAURITIUS LIMITED S 1950000.00 516.92
SYNGENE 2017-09-07 CAMAS INVESTMENTS PTE LIMITED P 4785000.00 461.00
SYNGENE 2017-09-07 SILVER LEAF OAK (MAURITIUS) LIMITED S 4784577.00 461.00
SYNGENE 2017-05-18 SILVER LEAF OAK (MAURITIUS) LIMITED S 9001200.00 475.00
SYNGENE 2017-05-18 THELEME MASTER FUND LIMITED P 9000000.00 475.00
SYNGENE 2016-12-02 SILVER LEAF OAK (MAURITIUS) LIMITED S 3250000.00 575.09
SYNGENE 2016-12-02 STEADVIEW CAPITAL MAURITIUS LIMITED P 3000000.00 575.00
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
SYNGENE 2017-11-23 UTI MUTUAL FUND P 450000.00 515.00
SYNGENE 2017-11-23 GAOLING FUND LP P 1500000.00 515.00
SYNGENE 2017-11-23 STEADVIEW CAPITAL MAURITIUS LIMITED S 1500000.00 515.00
SYNGENE 2017-11-23 STEADVIEW CAPITAL MAURITIUS LIMITED S 450000.00 515.00
SYNGENE 2017-05-18 THELEM PART P 9000000.00 475.00
SYNGENE 2017-05-18 SILVER LEAF OAK (MAURITIUS) LIMITED S 9000000.00 475.00
Dividend history
Ex Date Amount
2019-07-16 0.50
2018-07-17 1.00
2017-07-20 1.00
2016-03-17 1.00
Bonus Data
Company Name Split Date From Value To Value
Syngene International Ltd 2019-06-11 1.00 1.00
Split Data
Company Name Split Date From Value To Value